Diseases such as cancer and autoimmunity are often complex, caused by dysregulation of multiple processes
Current paradigm of drug discovery favors designs that target a single biological mechanism.
At Harmonic Discovery, we are creating a new generation of therapeutics that embrace the complexity of disease
We focus on therapeutics within the human kinome, a family of 500 proteins associated with diseases such as cancer, autoimmunity and neurodegeneration
Our interdisciplinary team represents the intersection of experts across medicinal chemistry, cheminformatics, computational biology and machine learning
We look for passionate innovators, radical
thinkers and collaborative builders
We are supported by several of best the investors operating at the interface of technology, biology and medicine